News

Dr. Malú Gámez Tansey discusses inflammation’s role in Alzheimer’s in New Scientist article.

Aligning Sciences Across Parkinson’s (ASAP) accelerates research efforts into underlying causes of disease.

Drs. Todd Golde, Malú Tansey and Adam Woods discuss Alzheimer’s research for new UF podcast, “From Florida.”

Dr. Malú Tansey co-authored a review in Nature Reviews Neurology presenting a roadmap for research into the immune system's role in Alzheimer's disease.

Dr. Malú Tansey discussed her research into Alzheimer's on NPR’s All Things Considered.

Findings lay groundwork for development of a blood test that could be used to help diagnose, treat Parkinson’s disease.

Dr. Malú Tansey discusses new role as journal’s editor-in-chief, career path and research focus.

We are excited to share the publication of our latest research that explored the molecular effects of long-term pharmacological LRRK2 inhibition in vivo. This comprehensive study was completed by Ph.D. candidate Jillian H. Kluss in the lab of Dr. Mark R. Cookson at the National Institute on Aging, NIH.

By Todd Taylor New research provides insight into how inflammation, bacterial populations and levels of short-chain fatty acids, or SCFAs, might be linked to the development of Parkinson’s disease. The study, published in the journal Molecular Neurodegeneration, was co-authored by Malú Tansey, co-director of UF’s Center for Translational Research in…

Researchers in the Center for Translational Research in Neurodegenerative Disease (CTRND) have published a review paper entitled “Remodeling Alzheimer-amyloidosis models by seeding” in the journal of Molecular Neurodegeneration. The paper was published by Neuroscience graduate student Brittany Ulm along with CTRND and McKnight Brain…